The American Gastroenterological Association and American Society for Gastrointestinal Endoscopy have released updated recommendations for surveillance and management of dysplasia in patients with inflammatory bowel disease.
The recommendations included in the statement are the result of collaboration from many stakeholders including endoscopists, pathologists, nurses, IBD experts, patients and more.
The statement was published in the journals GIE: Gastrointestinal Endoscopy and Gastroenterology.